|
|
|
| Efficacy of Salvia Miltiorrhiza Ligustrazine and Butylphthalide Injection on Angiotensin Ⅱ, Brain Natriuretic Peptide and Chemerin Factor in Patients with Acute Ischemic Stroke |
| LI Yong-feng, LI Wei, WANG Deng-qin, et al |
| Sishui People's Hospital, Jining,Shandong,273200 |
|
|
|
|
Abstract 【Objective】To investigate the effect of salvia miltiorrhiza ligustrazine and butylphthalide injection on angiotensin Ⅱ (Ang Ⅱ), brain natriuretic peptide (BNP) and adipokinin factor (chemerin) in patients with acute ischemic stroke. 【Methods】A total of 302 patients with acute ischemic stroke were randomly divided into the control group (treated with salvia miltiorrhiza ligustrazine injection, n=151) and the observation group (salvia miltiorrhiza ligustrazine + butylphthalide injection, n=151). After 2 weeks of continuous treatment, the NIHSS score was used to observe the neurological function of the patients. The serum levels of BNP, Ang Ⅱ, MDA (malondialdehyde), SOD (superoxide dismutase) and Chemerin were detected by enzyme linked immunosorbent assay.【Results】 The levels of serum BNP, Ang Ⅱ, Chemerin, BNP and MDA in the two groups were lower than those before treatment, and the SOD level was higher than that before treatment.The difference between the two groups was statistically significant (P<0.05). The NIHSS scores of the two groups were lower than those before treatment, and the difference between the two groups was statistically significant (P<0.05). The two groups were followed up with for 2 months. The incidence of poor prognosis in the observation group was 3.31% (5/151), which was lower than 9.93% (15/151) in the control group. The difference was statistically significant (χ2=5.355,P=0.021<0.05). 【Conclusion】The salvia miltiorrhiza ligustrazine combined with butylphthalide injection can obviously improve the neurological function of the patients with acute ischemic stroke, and the prognosis is better. It may be related to reducing the level of plasma BNP and MDA, Chemerin, alleviating the inflammatory reaction and improving the body's antioxidant capacity.
|
|
Received: 01 April 2019
|
|
|
|
|
|
[1] 伊恋,李星达,王建秀,等.依达拉奉联合丁苯酞治疗急性缺血性脑卒中的临床观察[J].中国药房, 2016, 27(29): 4130-4132.
[2] Badhiwala JH, Nassiri F, Alhazzani W,et al. Endovascular thrombectomy for acute ischemic stroke: a meta-analysis[J].JAMA,2015, 314(17): 1832-1843.
[3] Fransen PSS , Berkhemer OA , Lingsma HF , et al. Time to reperfusion and treatment effect for acute ischemic stroke: a randomized clinical trial[J].JAMA Neurol,2016, 73(2): 190-196.
[4] Menon B K , Esterre, Christopher D, Qazi E M , et al. Multiphase CT angiography: a new tool for the imaging triage of patients with acute ischemic stroke[J].Radiology,2015, 275(2): 510-520.
[5] 陈虹, 陈春莲, 陈毓青,等. Chemerin因子在缺血性脑卒中患者血清中的表达及其临床意义[J].实用临床医药杂志, 2014, 18(24): 22-24.
[6] Xue LX, Zhang T, Zhao YW, et al. Efficacy and safety comparison of DL-3-n-butylphthalide and Cerebrolysin: Effects on neurological and behavioral outcomes in acute ischemic stroke[J].Exp Ther Med,2016, 11(5): 2015-2020.
[7] Liu S, Wu JR, Zhang D, et al. Comparative efficacy of Chinese herbal injections for treating acute cerebral infarction: a network meta-analysis of randomized controlled trials[J].BMC Complement Altern Med,2018, 18(1): 120.
[8] Tsivgoulis G , Zand R , Katsanos AH , et al. Risk of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke and High Cerebral Microbleed Burden: A Meta-analysis[J].JAMA Neurol,2016, 73(6): 675-683. |
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2019, 36(8): 1561-1563. |
|
|
|
|
2019, Vol. 36 
